Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00301470
Other study ID # PI 2005 - 01
Secondary ID
Status Completed
Phase Phase 4
First received March 10, 2006
Last updated July 21, 2011
Start date March 2006
Est. completion date March 2008

Study information

Verified date October 2006
Source Central Hospital, Nancy, France
Contact n/a
Is FDA regulated No
Health authority France: Ministry of Health
Study type Interventional

Clinical Trial Summary

The objective of functional Uro MR is to add to an initial morphological phase, based on T2 and T1 weighted MR sequences, a sequential contrast-enhanced acquisition allowing to obtain functional semi-quantitative parameters from time-intensity curves from ROIs placed on the aorta, renal parenchyma and cavities. If the equivalence with the renal scintigraphy is demonstrated, it would be possible to have both the morphological and functional approach of an obstructed kidney in one MR examination, without exposure to diagnostic irradiation.


Description:

The initial management and the follow-up of a patient presenting with chronic or intermittent obstruction is depending on clinical, biological factors and of imaging data, including the presence and degree of dilatation of pelvo-caliceal cavities and of functional consequences of such an obstruction.

The primary objectives of the study are:

- to evaluate the feasibility and reliability of the measurement of the relative renal function by MR urography compared to renal scintigraphy in the management of patients presenting with chronic and intermittent urinary obstruction in adults and children.

- if the accuracy of the two methods is demonstrated as equivalent, to conduct a medico-economic evaluation of functional MR Urography compared to renal scintigraphy, and show potential lower costs.

The secondary objectives are:

- to compare the diagnostic accuracy of various parameters of analysis of functional MR urography data, previously published in the literature, and determine indicators for predicting urinary obstruction

- to evaluate the interest of these indicators after surgical treatment of obstruction, or during the follow-up of patients

- to draw up a program of analysis and treatment of MR urography data, available for all centres whatever their MR unit.

The current study has a multicentric, observational, prospective design for the evaluation of a diagnostic strategy. It includes 16 French hospitals.

The main clinical hypothesis is that during one single MR examination, by the association of a morphological diagnostic phase and a functional phase, it will be possible to extract functional parameters having the same accuracy that renal scintigraphy in the determination of relative renal function.

The targeted recruitment is of 550 patients for two years. The MR and scintigraphy collected data will be reviewed in one site by experts at the end of the study. The university hospital of Nancy is in charge of coordinating the study.

Points of expected impact of the study are:

1. a shortening of the duration of patients management by replacing two examinations (MR and scintigraphy) by one single examination (MR )

2. a reduction of delivered exposure to diagnostic radiation, by eliminating renal scintigraphy in the initial diagnostic and follow-up of children an adults.

3. potential applications in improving the spatial resolution of MR urography after correction of artefacts such as respiratory motion.

4. the publication of clinical recommendations by the National Scientific Societies supporting the trial.


Recruitment information / eligibility

Status Completed
Enrollment 550
Est. completion date March 2008
Est. primary completion date December 2007
Accepts healthy volunteers No
Gender Both
Age group 1 Month and older
Eligibility Inclusion Criteria:

children (age > 1 month) and adults chronic or intermittent urinary obstruction suspected by the demonstration of uni- or bilateral dilatation of pelvo-caliceal cavities by ultrasound or CT scan.

undergoing both renal scintigraphy and MR within a month

Exclusion Criteria:

acute urinary obstruction unilateral renal agenesia and ectopic kidney renal transplantation contra-indications to MR : pace-maker, claustrophobia contra-indications to the administration of Gadolinium chelates, including pregnancy, allergy

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Device:
MR urography
undergoing both renal scintigraphy and MR within a month

Locations

Country Name City State
France Chu Angers Angers
France Chu Bordeaux Bordeaux
France Chru Lille Lille
France Ap-Hm Marseille Marseille
France Fondation LENVAL Nice
France AP-HP Bicêtre Paris
France AP-HP Robert Debré Paris
France AP-HP Saint Vincent de Paul Paris
France AP-HP Trousseau Paris
France Chu Poitiers Poitiers
France Chu Reims Reims
France Chu Rennes Rennes
France Chu Rouen Rouen
France Chu Strasbourg Strasbourg
France Chu Tours Tours
France CHU NANCY Hôpital Brabois enfant Vandoeuvre les Nancy

Sponsors (1)

Lead Sponsor Collaborator
Central Hospital, Nancy, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Main medical criterion
Primary percentage of relative renal function of the obstructed kidney
Primary Main economical criterion
Primary reduction of patient's management cost in the case of a suspicion of chronic or intermittent urinary obstruction
Secondary acceptability of the method by patient
Secondary reliability of the functional indicators provided by the software programme
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06110299 - Room Air a Safe Alternative to Dye Injection in Ureterography N/A
Completed NCT01741454 - Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction Phase 4
Completed NCT00790686 - Tolerance and Effectiveness of Ureteral Stents MEMOKATH ® 051 in Chronic Strictures of the Ureter Phase 2
Completed NCT00568724 - Urinary Biomarkers as Predictors on Renal Function in Congenital Hydronephrosis N/A
Completed NCT00250406 - Assessment of Drug-eluting Ureteral Stent on Bacterial Adherence and Biofilm Formation Phase 2
Terminated NCT02419339 - Early Infancy Ureteral Reimplantation for Distal Ureteral Obstruction
Enrolling by invitation NCT05022199 - Use of SPY Fluorescent Angiography to Reduce Ureteroenteric Stricture Rate Following Urinary Diversion N/A
Enrolling by invitation NCT02160652 - Ureteral Reimplantation for the Treatment of Extrinsic Malignant Ureteral Obstruction N/A
Recruiting NCT01788865 - Efficacy and Safety of a Covered Self-expandable Dual-layered Metallic Mesh Stent (UVENTA) in Ureteral Obstruction Phase 4
Completed NCT03266770 - The RELIEF™ Ureteral Stent - Assessment of Retrograde Urinary Reflux and Distal Coil Bladder Position N/A
Completed NCT02744430 - Mirabegron as Medical Expulsive Therapy (MET) for Ureteral Stones and Ureteral Stent Pain Phase 2
Completed NCT00169650 - Laparoscopic Pyeloplasty Registry and Database N/A
Completed NCT01542593 - Evaluating Ureteral Length Using Computed Tomography (CT) N/A
Completed NCT00166361 - Drainage of Malignant Extrinsic Ureteral Obstruction Using the Memokath Ureteral Stent N/A
Completed NCT00142064 - A Randomized Control Trial Comparing Single vs. Multiple Application of Lidocaine Analgesia Prior to Urethral Catheterization Procedures Phase 2
Completed NCT04695951 - Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract Phase 2
Withdrawn NCT00199472 - Comparison of Dynamic Contrast Enhanced CT and Diuretic Renogram in The Evaluation of UPJO N/A